ScholarIQanswers from OpenAlex

Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma

PaperCitations, authors & open-access status

Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma have?

ScholarIQcitation count

Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma has 13 citations in the OpenAlex counts ScholarIQ stores.

When was Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma published?

ScholarIQyear

Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma has 2017 year in the ScholarIQ index.

What is the open-access status of Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma?

ScholarIQoa status

Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma has diamond oa status in the ScholarIQ index.

What is the DOI of Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma?

ScholarIQdoi

The DOI for Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma is on the source record.

What is the PMID of Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma?

ScholarIQpmid

The PMID for Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma is on the source record.

What is the OpenAlex record for Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma?

ScholarIQopenalex

The OpenAlex for Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial